Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 127 studies. A5418: A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus Disease A5257: Study of Three Compact ARV Regimens for Treatment of Naive HIV-1 Volunteers DAIDS Number 10670 Research Area Antiretroviral Strategies Study Status Concluded A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded IMPAACT 2049: LEAP DAIDS Number TBD Research Area Tuberculosis IMPAACT 2048: Open-Label, Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Infants at Risk of Acquiring HIV-1 Research Area Treatment IMPAACT 2047: Radiant-Moms Plus DAIDS Number TBD Research Area Tuberculosis Study Status In Development IMPAACT 2046: UPLIFT Study DAIDS Number TBD Research Area Brain and Mental Health Study Status In Development IMPAACT 2044: Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy DAIDS Number 39132 Research Area Therapeutics Study Status In Development IMPAACT 2042: Tatelo Plus DAIDS Number 39076 Research Area Cure and Immunotherapy Study Status Enrolling IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in People with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status In Development Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 13 Next page Next
A5418: A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus Disease
A5257: Study of Three Compact ARV Regimens for Treatment of Naive HIV-1 Volunteers DAIDS Number 10670 Research Area Antiretroviral Strategies Study Status Concluded
A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded
IMPAACT 2048: Open-Label, Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Infants at Risk of Acquiring HIV-1 Research Area Treatment
IMPAACT 2047: Radiant-Moms Plus DAIDS Number TBD Research Area Tuberculosis Study Status In Development
IMPAACT 2046: UPLIFT Study DAIDS Number TBD Research Area Brain and Mental Health Study Status In Development
IMPAACT 2044: Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy DAIDS Number 39132 Research Area Therapeutics Study Status In Development
IMPAACT 2042: Tatelo Plus DAIDS Number 39076 Research Area Cure and Immunotherapy Study Status Enrolling
IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in People with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status In Development
